NEW YORK (GenomeWeb) – Human Longevity and the Cleveland Clinic today announced a broad collaboration to sequence and analyze blood samples from the Cleveland Clinic's GeneBank.

The initial focus of the collaboration will be to perform whole-genome, cancer, and microbiome sequencing with the goal of discovering novel genes and pathways associated with heart disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.